Manufacturing of life-enhancing medicines boosted by new government funding

22 Nov 2018

Patients could receive faster treatment following boost to streamline the production of medicines and treatments.

Patients could soon receive faster treatment thanks to a multimillion pound government boost to streamline the production of medicines and treatments, including those used to treat blood cancers and inherited disorders.

Manufacturing of life-enhancing medicines boosted by new government funding

Companies in Northumberland, Oxford and London will adopt new digital technologies, such as artificial intelligence, to support the manufacture of next-generation medicines and treatments.

The £4.3 million funding aims to create more efficient and innovative methods for manufacturing medicines. The challenge works to set the UK apart as a leader with greater capacity for manufacture of safe, affordable and effective therapies.

Life Sciences Minister Lord Henley said: "New technology can help us live longer, healthier lives and the new projects announced today will improve the speed and accuracy with which medicines get to the people that need them.

"Advances in technology can help us address the challenges that an ageing society presents and we are backing the technologies of tomorrow in our modern Industrial Strategy, with the biggest increase in public research and development investment in UK history."

The three individual projects are:

  • Arc Trinova in Northumberland will use new technologies to speed up the process of the production of patient-specific medicines; it is currently a timely process dispensing individual doses from bulk because of the careful handling, labelling and batch release processes.
  • Oxford Biomedica will look to dramatically reduce the supply time for manufacturing by using a new digital and robotics framework to increase capacity, reduce waste and cut costs.
  • Autolus in London will look to avoid mix-ups of complex medicines on the supply chain by developing a computer-based system that will constantly monitor the operation, making adjustments to timing, co-ordination and production where necessary, improving the efficiency of the whole system and working at a pace that human operators cannot imitate.
  • One year on from the launch of the Industrial Strategy, this £7.3 million investment is the latest commitment from the £180 million Industrial Strategy Challenge Fund (ISCF) dedicated to leading-edge Medicines Manufacturing.

    Taking steps to improve patient access to life-saving treatments and medicines, Advanced Therapy Treatment Centres, working across the UK, will support the roll-out of cell and gene therapies as clinical trials show them to be safe and cost-effective. The centres bring together expert clinicians, researchers, scientists, developers and private companies to demonstrate how the therapies have impact on patients’ lives.

    Advanced therapies, including cell and gene therapies, represent the next generation of therapies that have the potential to offer treatments for a number of conditions including some blood cancers and inherited conditions for which there are currently limited treatment options.

    UK Research and Innovation (UKRI) is responsible for managing the Industrial Strategy Challenge Fund, which funds the winners of the Medicines Manufacturing Challenge.

    Dr Ian Campbell, Interim Executive Chair, Innovate UK for UKRI, said: "The projects announced today will bring real benefits to patients and boost the knowledge economy as part of the government’s modern Industrial Strategy. This is vital for the UK as a global leader in the development of advanced therapies and medicine manufacturing."

    Read More

    Related news

    Improving gut health with human milk oligosaccharides

    Improving gut health with human milk oligosaccharides

    17 May 2019

    2’-FL a very promising agent for digestive health across various age groups beyond infancy.

    Read more 
    Expert forecasts huge growth in Middle East manufacturing

    Expert forecasts huge growth in Middle East manufacturing

    16 May 2019

    UAE consumers and insurance companies are willing to pay for highest quality drug products.

    Read more 
    Colorcon's breakthrough for direct compression

    Colorcon's breakthrough for direct compression

    15 May 2019

    New starch-based excipient plays an important role in enhancing the stability of moisture-sensitive APIs.

    Read more 
    Legacy plans for lyophilisation boom

    Legacy plans for lyophilisation boom

    14 May 2019

    The increase in biologics is driving the growth in demand for lyophilization in vials.

    Read more 
    Lessons learned from early EU FMD adopters

    Lessons learned from early EU FMD adopters

    13 May 2019

    Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

    Read more 
    Catalent achieves global ISO accreditation

    Catalent achieves global ISO accreditation

    12 May 2019

    Company is one of the first CDMOs to receive award.

    Read more 
    Vibalogics increases capacity with a new 200-L line for virus manufacturing

    Vibalogics increases capacity with a new 200-L line for virus manufacturing

    9 May 2019

    Company has also invested in an Äkta-ready chromatography system for downstream processing and liquid handling equipment to deal with increased volumes.

    Read more 
    New SIMCA 16 software for multivariate data analytics

    New SIMCA 16 software for multivariate data analytics

    8 May 2019

    Makes model data easier to interpret for better process control.

    Read more 
    Recipharm launches its end-to-end inhalation offering

    Recipharm launches its end-to-end inhalation offering

    7 May 2019

    Offers a seamless outsourcing service for inhalation products, including MDIs, DPIs and nasal sprays.

    Read more 
    Accessible online courses designed to improve tablet compression tooling

    Accessible online courses designed to improve tablet compression tooling

    7 May 2019

    I Holland launches online training for all levels of pharmaceutical and nutraceutical professionals.

    Read more